您的位置: 首页 > 农业专利 > 详情页

Therapeutic DLL4 Binding Proteins
专利权人:
AbbVie Inc.
发明人:
Ming-Jiu Chen,Chung-Ming Hsieh,Jije Gu,Susan Morgan-Lappe,Yingchun Li
申请号:
US15582112
公开号:
US20190315855A1
申请日:
2017.04.28
申请国别(地区):
US
年份:
2019
代理人:
摘要:
DLL4 binding proteins are described herein, including antibodies, CDR-grafted antibodies, humanized antibodies, and DLL4 binding fragments thereof, proteins that bind DLL4 with high affinity, and DLL4 binding proteins that neutralize DLL4 and/or VEGF activity. The DLL4 binding proteins are useful for treating or preventing cancers and tumors and especially for treating or preventing tumor angiogenesis.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充